Revenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 millionReceived CE Mark for LungFit PH® in ...
The following is a summary of “Artificial Intelligence-Based Early Prediction of Acute Respiratory Failure in the Emergency ...
Nasdaq’s determination is based on the Company meeting all other applicable requirements for listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and the Company’s ...
When using high-flow nasal cannula (HFNC), setting a higher flow rate of 60 vs 40 L/min for post-extubation care did not improve key outcomes.